TNKS-IN-3 (Compound 6) is a TNKS2 inhibitor (Ki: 8.5 nM). TNKS-IN-3 has good activity (IC50: 71 nM) and can effectively inhibit the WNT/beta-catenin signaling pathway. TNKS-IN-3 can be used in the research of diseases such as cancer and fibrosis[1].
Molekulargewicht:
553.63
Formel:
C30H27N5O4S
Target-Kategorie:
PARP
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
